TWD
CORT icon

True Wealth Design’s Corcept Therapeutics CORT Stock Holding History

True Wealth Design’s Portfolio CORT Stock Details CORT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$46K Buy
+529
New +$31.9K 0.01% 521
2026
Q1 		– Sell
-218
Closed -$7.59K – 2733
2025
Q4 		$7.59K Sell
218
-73
-25% -$5.73K ﹤0.01% 940
2025
Q3 		$24.2K Buy
291
+90
+45% +$6.51K 0.01% 542
2025
Q2 		$14.8K Buy
201
+2
+1% +$145 0.01% 461
2025
Q1 		$22.7K Sell
199
-9
-4% -$548 0.01% 324
2024
Q4 		$10.5K Buy
208
+15
+8% +$786 ﹤0.01% 416
2024
Q3 		$8.93K Buy
+193
New +$6.86K ﹤0.01% 445

Other funds holding CORT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $3.66B AUM 57.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PA
Parallel Advisors San Francisco, California $6.56B AUM 32.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

True Wealth Design's CORT Position: Q2 2026 in Review

True Wealth Design opened a new position in Corcept Therapeutics (CORT) in Q2 2026: 529 shares worth $46K. The stake represents 0.01% of the portfolio and ranks #521 among its holdings. This is a return to the name: True Wealth Design previously reported a position in CORT as recently as Q4 2025.

True Wealth Design first reported a position in CORT in Q3 2024 and has held it in 7 quarters since. 422 funds tracked by Wall St. Rank hold CORT as of Q2 2026.

  • True Wealth Design held 529 shares of Corcept Therapeutics worth $46K as of Q2 2026.
  • Corcept Therapeutics was a new True Wealth Design position in Q2 2026.
  • Corcept Therapeutics made up 0.01% of True Wealth Design's portfolio in Q2 2026, its #521 holding.
  • True Wealth Design first reported a position in Corcept Therapeutics in Q3 2024 and has held it in 7 quarters since.
  • 422 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q2 2026.

Based on True Wealth Design's 13F filing for Q2 2026, filed 16 Jul 2026.